Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) - Net Worth and Insider Trading

Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) Net Worth

The estimated net worth of Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) is at least $181,630 dollars as of 2024-09-24. Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) is the Member of 13(d) group of Emergent BioSolutions Inc and owns about 29,972 shares of Emergent BioSolutions Inc (EBS) stock worth over $181,630. Details can be seen in Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr)'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) has not made any transactions after 2007-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr)

To

Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) owns 1 companies in total, including Emergent BioSolutions Inc (EBS) .

Click here to see the complete history of Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr)’s form 4 insider trades.

Insider Ownership Summary of Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr)

Ticker Comapny Transaction Date Type of Owner
EBS Emergent BioSolutions Inc 2007-03-08 other: Member of 13(d) group

Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) Latest Holdings Summary

Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) currently owns a total of 1 stock. Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) owns 29,972 shares of Emergent BioSolutions Inc (EBS) as of March 8, 2007, with a value of $181,630.

Latest Holdings of Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr)

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EBS Emergent BioSolutions Inc 2007-03-08 29,972 6.06 181,630

Holding Weightings of Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr)


Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) Form 4 Trading Tracker

According to the SEC Form 4 filings, Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) has made a total of 0 transactions in Emergent BioSolutions Inc (EBS) over the past 5 years. The most-recent trade in Emergent BioSolutions Inc is the sale of 0 shares on March 8, 2007, which brought Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) around $0.

Insider Trading History of Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr)

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) Ownership Network

Ownership Network List of Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr)

No Data

Ownership Network Relation of Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr)

Insider Network Chart

Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) Owned Company Details

What does Emergent BioSolutions Inc do?

Who are the key executives at Emergent BioSolutions Inc?

Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) is the other: Member of 13(d) group of Emergent BioSolutions Inc. Other key executives at Emergent BioSolutions Inc include SVP & Bioservices William Hartzel , Interim CEO Miller H Haywood Iii , and SVP & Products Business Paul Anthony Williams .

Emergent BioSolutions Inc (EBS) Insider Trades Summary

Over the past 18 months, Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) made no insider transaction in Emergent BioSolutions Inc (EBS). Other recent insider transactions involving Emergent BioSolutions Inc (EBS) include a net sale of 16,449 shares made by Kathryn C Zoon ,

In summary, during the past 3 months, insiders sold 0 shares of Emergent BioSolutions Inc (EBS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,449 shares of Emergent BioSolutions Inc (EBS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,449 shares.

Emergent BioSolutions Inc (EBS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Emergent BioSolutions Inc Insider Transactions

No Available Data

Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) Mailing Address

Above is the net worth, insider trading, and ownership report for Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr). You might contact Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr) via mailing address: 33 King Street, London X0 Sw1y 6rj.

Discussions on Merlin General Partner Ii Ltd (as Managing Partner Of The Merlin Biosciences Fund Gbr)

No discussions yet.